Published in Bioethics on February 01, 2017
Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women. Science (2010) 35.19
Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups. Int J Qual Health Care (2007) 24.41
What makes clinical research ethical? JAMA (2000) 14.34
International ethical guidelines for biomedical research involving human subjects. Bull Med Ethics (2002) 12.36
What makes clinical research in developing countries ethical? The benchmarks of ethical research. J Infect Dis (2004) 9.65
High coverage of ART associated with decline in risk of HIV acquisition in rural KwaZulu-Natal, South Africa. Science (2013) 8.24
Sampling for qualitative research. Fam Pract (1996) 6.06
Reflections and recommendations on research ethics in developing countries. Soc Sci Med (2002) 5.27
Grand challenges in global health: community engagement in research in developing countries. PLoS Med (2007) 4.75
Health and health care in South Africa--20 years after Mandela. N Engl J Med (2014) 3.16
Moral standards for research in developing countries: from "reasonable availability" to "fair benefits". Hastings Cent Rep (2004) 2.97
Ethics are local: engaging cross-cultural variation in the ethics for clinical research. Soc Sci Med (1992) 2.26
Defining and describing benefit appropriately in clinical trials. J Law Med Ethics (2000) 2.19
Generating best evidence from qualitative research: the role of data analysis. Aust N Z J Public Health (2007) 2.06
Research at the auction block: Problems for the fair benefits approach to international research. Hastings Cent Rep (2010) 1.78
Moral imagination: the missing component in global health. PLoS Med (2005) 1.56
Responsibilities in international research: a new look revisited. J Med Ethics (2010) 1.39
Benefits and payments for research participants: experiences and views from a research centre on the Kenyan coast. BMC Med Ethics (2012) 1.24
Promoting the social value of research in Kenya: examining the practical aspects of collaborative partnerships using an ethical framework. Soc Sci Med (2008) 1.20
Community engagement and the human infrastructure of global health research. BMC Med Ethics (2014) 1.10
Ethics in practice: the state of the debate on promoting the social value of global health research in resource poor settings particularly Africa. BMC Med Ethics (2011) 1.01
Forms of benefit sharing in global health research undertaken in resource poor settings: a qualitative study of stakeholders' views in Kenya. Philos Ethics Humanit Med (2012) 0.97
For-profit clinical trials in developing countries--those troublesome patient benefits. Am J Bioeth (2010) 0.96
Racial differences in public perceptions of voluntariness of medical research participants in South Africa. Soc Sci Med (2005) 0.96
'It looks like you just want them when things get rough': civil society perspectives on negative trial results and stakeholder engagement in HIV prevention trials. Dev World Bioeth (2012) 0.89
Community members' engagement with and involvement in genomic research: lessons to learn from the field. Dev World Bioeth (2013) 0.88
"When they see us, it's like they have seen the benefits!": experiences of study benefits negotiations in community-based studies on the Kenyan Coast. BMC Med Ethics (2014) 0.87
Stakeholders understanding of the concept of benefit sharing in health research in Kenya: a qualitative study. BMC Med Ethics (2011) 0.85
Improving ethical and participatory practice for marginalized populations in biomedical HIV prevention trials: lessons from Thailand. PLoS One (2014) 0.82
Debating Ethics in HIV Research: Gaps between Policy and Practice in Nigeria. Dev World Bioeth (2014) 0.81
The fair benefits approach revisited. Hastings Cent Rep (2010) 0.77
Child consent in South African law: implications for researchers, service providers and policy-makers. S Afr Med J (2010) 2.37
Beyond the checklist: assessing understanding for HIV vaccine trial participation in South Africa. J Acquir Immune Defic Syndr (2006) 1.51
Resource and needs of research ethics committees in Africa: preparations for HIV vaccine trials. IRB (2006) 1.44
Mapping African ethical review committee activity onto capacity needs: the MARC initiative and HRWeb's interactive database of RECs in Africa. Dev World Bioeth (2012) 1.32
African AIDS vaccine programme for a coordinated and collaborative vaccine development effort on the continent. PLoS Med (2008) 1.23
Promoting research integrity in Africa: an African voice of concern on research misconduct and the way forward. Dev World Bioeth (2013) 1.00
How well does South Africa's National Health Act regulate research involving children? S Afr Med J (2005) 0.99
HIV vaccine research--South Africa's ethical-legal framework and its ability to promote the welfare of trial participants. S Afr Med J (2005) 0.99
Ethical issues in medical research in the developing world: a report on a meeting organised by Fondation Mérieux. Dev World Bioeth (2008) 0.95
Research ethics capacity building in Sub-Saharan Africa: a review of NIH Fogarty-funded programs 2000–2012. J Empir Res Hum Res Ethics (2014) 0.93
Improving understanding of clinical trial procedures among low literacy populations: an intervention within a microbicide trial in Malawi. BMC Med Ethics (2012) 0.93
'It looks like you just want them when things get rough': civil society perspectives on negative trial results and stakeholder engagement in HIV prevention trials. Dev World Bioeth (2012) 0.89
Stakeholder perspectives on ethical challenges in HIV vaccine trials in South Africa. Dev World Bioeth (2010) 0.88
Payment of trial participants can be ethically sound: moving past a flat rate. S Afr Med J (2008) 0.87
HIV prevention responsibilities in HIV vaccine trials: complexities facing South African researchers. S Afr Med J (2010) 0.85
Preparing developing countries for efficacy trials. Curr Opin HIV AIDS (2006) 0.84
Ethical issues in adolescent HIV research in resource-limited countries. J Acquir Immune Defic Syndr (2014) 0.84
Child consent in South African law: implications for researchers, service providers and policy-makers. S Afr Med J (2011) 0.83
A strategy for developing future academic leaders for South Africa in a resource-constrained environment. Acad Med (2014) 0.83
Treatment needs in HIV prevention trials: using beneficence to clarify sponsor-investigator responsibilities. Dev World Bioeth (2010) 0.81
Stakeholder views of ethical guidance regarding prevention and care in HIV vaccine trials. BMC Med Ethics (2014) 0.81
Compensation for research-related injury in NIH-sponsored HIV/AIDS clinical trials in Africa. J Empir Res Hum Res Ethics (2013) 0.80
Homicide-suicide in Durban, South Africa. J Interpers Violence (2009) 0.79
Civil society perspectives on negative biomedical HIV prevention trial results and implications for future trials. AIDS Care (2012) 0.78
Access to treatment in HIV prevention trials: perspectives from a South African community. Dev World Bioeth (2009) 0.76
Response to 'HIV vaccine trials: reconsidering the therapeutic misconception and the question of what constitutes trial-related injuries'. Dev World Bioeth (2008) 0.75
The burden of diabetes mellitus in KwaZulu-Natal's public sector: A 5-year perspective. S Afr Med J (2016) 0.75
JERHRE's Journey. J Empir Res Hum Res Ethics (2017) 0.75
Ethics review in a developing country: a survey of South African social scientists' experiences. J Empir Res Hum Res Ethics (2009) 0.75